← Back to Search

Pupillometry for Anesthesia

N/A
Recruiting
Led By Daniel Abelson, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to extubation
Awards & highlights

Study Summary

This trial looks at whether measuring the size of a child's pupil can predict when they are ready to be taken off a breathing machine.

Who is the study for?
This trial is for children who are undergoing surgery that requires general anesthesia and endotracheal intubation. It's specifically aimed at those in good or stable condition (ASA Physical Status Class I and II). Children with more complex health issues won't be included.Check my eligibility
What is being tested?
The study is testing the use of pupillometry, which measures pupil response, to determine when a child under anesthesia is ready to have their breathing tube removed after surgery.See study design
What are the potential side effects?
Since pupillometry is a non-invasive monitoring technique, it doesn't introduce additional side effects beyond those associated with standard anesthesia care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after extubation
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after extubation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Extubation success
Secondary outcome measures
Tracheal Extubation
Other outcome measures
Respiration

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2Experimental Treatment1 Intervention
Deep extubation guided by pupillometry -- at < 0.5 MAC of vapor + propofol and fentanyl
Group II: Group 1Active Control1 Intervention
Traditional deep extubation at 1.5 minimum alveolar concentration (MAC)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pupillometry
2017
Completed Phase 1
~330

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,451 Total Patients Enrolled
Daniel Abelson, MDPrincipal InvestigatorUCSF Benioff Children's Hospital Oakland

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies for participants in this investigation?

"Affirmative. The details listed on clinicaltrials.gov indicate that this medical trial, which was first advertised on June 20th 2022, is actively looking for recruits. At present, the team requires 20 individuals to be sourced from a single site."

Answered by AI

How many individuals have volunteered to be participants in this experiment?

"Affirmative. According to the information present on clinicaltrials.gov, this research endeavour is presently looking for participants and was initially published on June 20th 2022. The most recent edit occurred September 22nd 2022 and the project needs to recruit a total of 20 study subjects from one medical centre."

Answered by AI

Who are the ideal candidates for enrollment in this experiment?

"This research is looking for 20 minors, aged between 2 and 10 years old, with laryngismus. Additionally, they must also be receiving general anesthesia or endotracheal intubation prior to surgery."

Answered by AI

Are octogenarians eligible for this experiment?

"According to the study's inclusion parameters, only individuals aged 2-10 are eligible for enrollment. 32 studies have been conducted with patients younger than 18 and 93 studies were focused on those over 65."

Answered by AI
~7 spots leftby Apr 2025